Vivimed Labs Limited (NSE:VIVIMEDLAB)

Vivimed Labs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	582	410	410	547	1,202	1,335
Market Cap Growth	-60.45%	-	-25.00%	-54.48%	-9.94%	122.07%
Enterprise Value	4,412	4,182	3,585	4,190	4,763	13,313
Last Close Price	7.02	4.95	4.95	6.60	14.50	16.10
Forward PE	-	3.72	3.72	3.72	3.72	3.72
PS Ratio	0.53	0.34	0.26	0.29	0.50	0.15
PB Ratio	-1.21	-1.17	-7.52	1.39	0.33	0.31
P/TBV Ratio	-	-	-	-	0.58	0.48
P/FCF Ratio	-	-	-	1.80	10.80	0.24
P/OCF Ratio	-	-	-	1.55	4.37	0.24
EV/Sales Ratio	4.05	3.47	2.25	2.23	2.00	1.53
EV/EBITDA Ratio	193.53	-	-	-	-	27.37
EV/FCF Ratio	-19.02	-	-	13.80	42.79	2.35
Debt / Equity Ratio	-8.01	-10.70	-69.36	9.67	0.99	0.75
Debt / EBITDA Ratio	168.44	-	-	-	-	6.69
Debt / FCF Ratio	-	-	-	12.55	32.24	0.57
Asset Turnover	-	0.13	0.16	0.17	0.19	0.50
Inventory Turnover	-	1.00	1.00	1.71	0.63	1.00
Quick Ratio	0.21	0.18	0.21	0.18	0.25	0.34
Current Ratio	0.78	0.80	0.84	0.80	1.36	1.55
Return on Equity (ROE)	-	-	-267.64%	-162.76%	-17.00%	-11.36%
Return on Assets (ROA)	-	-1.93%	-2.69%	-11.34%	-1.23%	-0.24%
Return on Invested Capital (ROIC)	-5.85%	-8.11%	-10.61%	-36.21%	-3.42%	-0.56%
Return on Capital Employed (ROCE)	-4.00%	-5.60%	-7.70%	-35.90%	-2.80%	-0.70%
Earnings Yield	-41.87%	-77.87%	-110.73%	-600.36%	-56.27%	-53.85%
FCF Yield	-39.85%	-15.31%	-63.42%	55.47%	9.26%	424.95%
Buyback Yield / Dilution	-0.15%	-	-	-	-	-
Total Shareholder Return	-0.15%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.